Investor Stock List
Ranked #8,505 of 8,699 institutional investors

Ally Bridge Group (NY) LLC

New York, NY

$31.4M
US stock portfolio at live prices · today +$18K (+0.06%)
Market closed. Prices as of Nov 20, 9:11 AM ET
Value at quarter end (Q3 2026)
$43.4M
Change from Q2 2026
−$34.2M (−44.06%)
Positions
14 · 4 new, 12 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $32.6M of stock.

Holdings

Q3 2026 13F, live prices
EWTX 24.3%AMLX 15.2%OBX 11.7%NERV 11.2%STTK 9.05%
StockSharesValue, live% of portfoliovs Q2 2026
EWTX Edgewise Therapeutics, Inc.185,430$7.6M24.3%Added +123%
AMLX Amylyx Pharmaceuticals, Inc.182,000$4.8M15.2%New
OBX Obsidian Therapeutics, Inc.302,449$3.7M11.7%New
NERV Minerva Neurosciences, Inc.1,655,500$3.5M11.2%Reduced −24%
STTK Shattuck Labs, Inc.625,190$2.8M9.05%New
ANTX AN2 Therapeutics, Inc.526,315$2.7M8.75%Unchanged
PMN ProMIS Neurosciences, Inc.620,319$2.0M6.34%Unchanged
EPRX Eupraxia Pharmaceuticals Inc.231,122$1.4M4.50%Reduced −8%
AVTX Avalo Therapeutics, Inc.134,429$907K2.89%Reduced −10%
IVA Inventiva S.A.227,250$784K2.50%Reduced −64%
VOGX Vogenx, Inc.32,701$419K1.33%New
ASMB Assembly Biosciences, Inc.18,298$412K1.31%Reduced −87%
TRAW Traws Pharma, Inc.786,236$181K0.58%Unchanged
CATX Perspective Therapeutics, Inc.163,634$128K0.41%Reduced −78%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
TRAX First Tracks Biotherapeutics, Inc.284,287$12.6M
WHWK Whitehawk Therapeutics, Inc.817,939$2.6M
CLYM Climb Bio Inc249,172$2.3M
AXSM Axsome Therapeutics, Inc.16,493$2.2M
KURA Kura Oncology, Inc.290,000$2.1M
IDYA IDEAYA Biosciences, Inc.67,500$1.8M
SLDB Solid Biosciences Inc.255,959$1.6M
CTMX CytomX Therapeutics, Inc.775,000$1.6M
OVID Ovid Therapeutics Inc.624,561$1.5M
PALI Palisade Bio, Inc.1,229,000$1.1M
ALMS Alumis Inc.76,459$331K
IBIO iBio, Inc.390,147$313K